Crowdfunding for Science: Models of Best Practice
It’s Not Just the Science That Has to Be Memorable
Gut Microbiome: Both a Friend and a Foe
We Need to Stay on the Gut Microbiome’s Good Side or Risk Microbiota Dysbiosis
Genome Editing B.C. (Before CRISPR)
Lasting Lessons from the “Old Testament”
Applications of CRISPR/Cas9 Technology in Translational Research on Solid-Tumor Cancers
Efforts Are Underway to Move CRISPR/Cas9 from Bench to Bedside
For full access to this article login to GEN Select now.
Raising the Bar of Cell Line Authentication
Researchers May Be Slow to Implement Protocols Unless They Are Pressured
- Imagine publishing a paper, accepting a research grant, or recruiting patients for a clinical trial only to discover that the esophageal cancer cell line used in your disease model actually came from a different tumor type. It’s a scientist’s nightmare, but it became an unfortunate reality for researchers working ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.